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ABSTRACT
Objective: Verify the effects of the association between 
Biosilicate® and ultrasound and, Biosilicate® and laser 
in bone consolidation process of rats, through the biome-
chanical and histological analysis.  Methods: Forthy male 
rats were used. The  animals were randomized into four 
groups (n=10): control group fracture no treated (CGF); 
group treated with Biosilicate® (BG); group treated with 
Biosilicate® and laser (BLG); group treated with Biosili-
cate® and ultrasound (BUG). Results: The biomechani-
cal analysis showed no significant difference among any 
groups after 14 days post-surgery. In the morphometric 
analysis, the control group showed moderate presence of 
new formed bone tissue inside the defects areas and the 
Biosilicate® group showed similar results. Despite those 
facts, the biomaterial osteogenic potential was demon-
strated by the great amount of cells and bone tissue around 
the particles. Curiously, the Biosilicate® plus laser or ul-
trasound groups showed lower amounts of bone tissue 
deposition when compared with control fracture and Bio-
silicate® groups. Conclusion: The data from this study 
can conclude that Biosilicate® was able to accelerate and 
optimized the bone consolidation, through the modulation 
of the inflammatory process and the stimulation of new 
bone formation. However, when resources were associated, 
there are no positive results.
Keywords - Bone Tissue; ultrasound; Laser;  Biocompat-
ible Materials; Rats
INTRODUCTION
Bone repair is a highly complex regenerative process 
that includes interactions between a series of biological 
events, such as active gene synthesis and the action of a 
large number of cells and proteins, which will give rise 
to restoration of the integrity of the bone tissue(1). How-
ever, over the course of this process, changes culminat-
ing in regenerative deficiencies and consequent delayed 
consolidation and even bone nonunion may occur. It 
has been estimated that in the United States, out of the 
6.2 million fractures that occur every year, around 10% 
evolve to non-consolidation and pseudarthrosis(1). 
Within this context, various biophysical and bio-
chemical advances have been studied in an attempt to 
minimize the bone consolidation time and diminish the 
chances of possible complications stemming from the 
abnormal regeneration process(2). Among the topics stu-
died have been the effects of treatments such as applica-
tion of morphogenetic bone proteins, bioactive materials, 
use of low-intensity ultrasound (US) and use of low-
level laser therapy (LLLT)(3). 
Bioactive materials or biomaterials are defined as 
materials that are capable of producing a specific bio-
logical response at the interface between the material 
and the tissue, thus forming a bond between them, wi-
thout being toxic or promoting immunological respon-
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ses(4,5). In the 1990s, our research group developed a 
highly bioactive glass ceramic with high-performance 
mechanical properties, named Biosilicate®(6). Some 
studies have been demonstrating the osteogenic po-
tential of Biosilicate®, both in vitro and in vivo(5,7).
In addition, LLLT and US have also been high-
lighted through their osteogenic potential. The effects 
from this therapy have been reported by several au-
thors. Renno et al(8) and Stein et al(9) showed that there 
was a significant increase in osteoblast proliferation 
after irradiation with laser at 830 nm and 20 J/cm2. 
Moreover, the laser seemed to accelerate the fracture 
repair process and caused increases in callus volume 
and bone mineral density(10). Pinheiro et al(11) showed 
that laser (830 nm, 40 mW, 4.8 J/cm2) was capable of 
increasing the quantity of mineralized bone tissue in 
fractures induced in the femurs of rats. US was found 
to have the effects of increasing cell proliferation and 
accelerating bone consolidation after a fracture, and 
increasing the mechanical strength of the bone callus 
in rats and rabbits(12,13). Takikawa et al(12) observed 
in an experimental study that, after six weeks of US 
treatment, it had significantly increased the consolida-
tion rate in fractures with bone nonunion, compared 
with the control group. The same results were found 
by Sun et al(14) and Lirani et al(15). 
As stated above, biomaterials, US and LLLT have 
been emerging as promising alternatives for treating 
bone fractures. These resources not only present great 
osteogenic potential but also constitute noninvasive 
treatment methods and present relatively low cost. 
Studies investigating the effects from associating 
these resources in the consolidation process are scarce 
in the literature. Within this context, the present study 
had the aim of ascertaining the effects from associ-
ating Biosilicate® with US and LLLT in the bone 
consolidation process in rats, from biomechanical and 
histological analyses.
METHODOLOGY
Forty male Wistar rats weighing between 280 and 
320 g were used in this study. The animals were kept 
under controlled environmental conditions (dark/light 
cycle of 12 hours each, cleaned environment, tem-
perature of 24 ± 2 oC and adequate ventilation), where 
they received ordinary feed and water ad libitum. This 
study was approved by the Ethics Committee for Ani-
mal Experimentation of the Federal University of São 
Carlos (Opinion Report 023/2006).
The animals were randomly distributed into four 
groups (n = 10): control group with fracture (FG): 
the rats in this group were subjected to a fracture but 
did not receive any treatment; Biosilicate® group 
(BG): the rats were subjected to a fracture and were 
treated with Biosilicate®; Biosilicate® + laser group 
(BLG): the rats were subjected to a fracture and were 
treated with an association of Biosilicate® + laser; 
Biosilicate® + US (BUSG): the rats were subjected 
to a fracture and were treated with an association of 
Biosilicate® + US.
To produce the bone defects, the rats were anes-
thetized in accordance with their body weight, using 
a mixture of ketamine and xylazine (80/10 mg/kg). 
After anesthesia, shaving and asepsis, an incision was 
made in both tibias. With the aid of a mini-drill fitted 
with a milling disc of 2.0 mm in diameter, irrigated 
with physiological serum, bone defects were made 
in the middle third of the tibia (10 mm below the 
knee joint). The procedure was completed by suturing 
the muscle and skin using monofilament 4.0 nylon 
thread, with a distance of 1 cm between the stitches, 
and cleaning the site. The animals continued to be 
provided with free access to water and food until the 
time of sacrifice.
TREATMENTS 
Biomaterial
The bioactive material used was Biosilicate®. This 
is a highly bioactive glass ceramic composed of the 
chemical elements silicon, oxygen, sodium, calcium 
and phosphorus (Si, O, Na, Ca and P), which are 
released into solution in the form of Si(OH)4, Na+, 
Ca2+ and PO42-. Biosilicate® was used in this study 
in granulated form, with grain size of approximately 
180-212 μm. This was introduced into the defect by 
means of an appropriate spatula, just after the defect 
was made, and the circular fracture was completely 
filled. The details of the composition of Biosilicate® 
and the thermal treatment are described in the patent 
WO 2004/074199.
low-level laser
The device used was a portable DMC laser: 
THERALASE version 24, class 3B, Ga-Al-As diode, 
with a wavelength of 830 nm, continuous emission, 
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output power of 100 mW, power density of 3.57 W/
cm2, beam area of 0.028 cm² and divergence of 
1.5°. The application was made at just one point, 
with a fluence of 120 J/cm², for 34 seconds, thereby 
supplying 3.4 J of energy. 
low-intensity ultrasound
A portable ultrasound device was used (Exogen, 
United States), in pulsed mode with a burst of 1.5 
MHz, pulse width of 200 us, pulse repetition fre-
quency of 1 kHz and intensity of 30 mW/cm2, for 
20 minutes. 
The treatments started immediately after the opera-
tive procedure, with subsequent applications on the 
2nd, 4th, 6th, 8th, 10th and 12th days after the operation, 
thus totaling seven applications in 14 days. 
On the 14th day after the experimental procedure, 
the animals were sacrificed by means of a lethal dose 
of anesthesia, injected intraperitoneally. The tibias 
were then extracted and the soft tissue was removed 
for subsequent analyses.
Biomechanical analysis
The biomechanical analysis was done by means of 
the three-point flexion test. The test was done on the 
animals’ right tibia in all the groups. The biomechani-
cal tests were performed on the Instron universal test-
ing machine (model 4444), at room temperature. To 
carry out the tests, a load cell of maximum capacity 1 
kN and a preload of 5 N were used. A metal support 
of 3.8 cm in length was used, thus exposing only 1.8 
cm of the test body. The tibias were positioned with 
the defect region on the underside, such that this re-
gion would be subjected to traction. From this test, 
the following variables were obtained: maximum load 
(kN), resilience (J) and tenacity (J). 
Histological analysis
The tibias were subjected to decalcification in 
MORSE decalcifying solution (20% sodium citrate 
and 50% formic acid in equal parts) and were then 
processed in paraffin. The paraffin blocks were cut 
longitudinally into slices of standardized thickness 
5.0 μm and histological slides were produced. The 
sections were then stained with hematoxylin and eo-
sin (HE) for qualitative analysis, and with Masson’s 
trichrome (MT) for morphometry. Each animal was 
represented by two histological slides, each contain-
ing a series of at least three consecutive slices.
The histopathological analysis was carried 
out using an optical microscope (Olympus, Optical 
Co. Ltd, Tokyo, Japan). Modifications such as the 
presence of neoformed bone, medullary tissue, pres-
ence of inflammatory infiltrate and granulation tissue 
were taken into consideration. 
The morphometry of the neoformed bone area in 
the  region of each animal’s defect was measured us-
ing the Motican 5.0 image analysis system. The slides 
were observed in two areas of the cortical region of 
the defect. The two areas were selected and named C1 
and C2, corresponding to the upper and lower cortical 
areas of the defect. The neoformed bone tissue present 
in these regions was measured and the area seen in 
the 10X objective lens was registered. After this, the 
areas were summed, thus resulting in the total area of 
neoformed tissue in the defect.
STATISTICAL ANALYSIS 
The data were analyzed statistically using descrip-
tive techniques such as tables and graphs, in the form 
of means and standard deviations. The Shapiro-Wilk 
W test was used on all the variables to ascertain 
whether they presented normal distribution. If the dis-
tribution was normal, comparisons were made using 
one-way ANOVA with the post-hoc Tukey-HSD test. 
If the distribution was not normal, the Kruskal-Wallis 
test was used. The analyses were performed using the 
Statistica software, version 7.0. The significance level 
was taken to be p ≤ 0.05.
RESULTS
Biomechanical analysis
Table 1 presents the means and standard deviations 
of the mechanical properties of all the experimental 
groups. The statistical analysis did not demonstrate 
any significant differences between any of the groups 
after the experimental period of 14 days.
Table 1 – Biomechanical properties of the tibias of the experi-
mental groups (mean ± SD).
Group Maximum load (kN) Tenacity (J) Resilience (J)
FG 0.064 ± 0.020 0.057 ± 0.011 0.029 ± 0.012 
BG 0.063 ± 0.014 0.069 ± 0.018 0.033 ± 0.010 
BUSG 0.053 ± 0.012 0.049 ± 0.018 0.027 ± 0.010
BLG  0.049 ± 0.014 0.057 ± 0.020 0.028 ± 0.007 
FG: fracture control; BG: Biosilicate®; BUSG: Biosilicate® + ultrasound; BLG: Biosilicate® + laser.
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Figure 1 – Photomicrograph of the morphological findings from the different experimental groups. In the region of the defect, granu-
lation tissue (arrows) and neoformed tissue (*) can be observed, and in the respective groups, the presence of the biomaterial (B). 
(A) FG: fracture control; (B) BG: Biosilicate®; (C) BUSG: Biosilicate® + ultrasound; (D) BLG: Biosilicate® + laser. Staining: H.E.
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Qualitative histological analysis
It can be seen from Figure 1A that the control 
group had moderate presence of neoformed bone tis-
sue inside the defects and moderate presence of in-
flammatory infiltrate. The animals treated only with 
Biosilicate® presented histopathological findings 
similar to those of the animals in the control group, 
with a moderate quantity of neoformed bone tissue 
(Figure 1B). Nonetheless, the osteogenic potential of 
the biomaterial was seen, given that there was great 
presence of cells and bone tissue around the particles. 
Interestingly, the groups with Biosilicate® in associa-
tion with therapeutic laser and with US demonstrated 
some presence of cellular infiltrate, but with smaller 
amounts of neoformed bone tissue deposition than 
in the control group and the group with Biosilicate® 
alone (Figures 1C and 1D).
morphometric analysis
It can be seen in Figure 2 that the groups treated 
with the associations of Biosilicate® + laser and Bio-
silicate® + US presented significantly smaller quanti-
ties of neoformed bone tissue area than shown by the 
untreated control group and the group treated only 
with Biosilicate®. However, no difference was found 
between these groups. 
DISCUSSION
Use of biomaterials for bone repair has grown 
considerably over recent years(16). The present study 
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Figure 2 - Means and standard deviations of the area neoformed 
bone of the different experimental groups. a p < 0.05 vs FG; * p 
< 0.05 vs BG. FG: fracture control; BG: Biosilicate® ; BLG: Bio-
silicate® + laser; BUSG: Biosilicate®  + ultrasound.
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showed the osteogenic potential of Biosilicate®, 
given that it was possible to see the deposition of 
neoformed bone tissue around the biomaterial par-
ticles. However, the quantity of bone tissue was no 
greater than in the control group, possibly because 
of the short experimental period used in this study. 
Moreover, no modifications to the biomechanical 
properties were observed.
In the present study, we used a highly bioactive 
glass ceramic material called Biosilicate®. It has been 
reported in the literature that when a bioactive mate-
rial comes into contact with body fluids, a layer of hy-
droxycarbonate apatite is formed on the surface, thus 
promoting osteogenesis(17). Previous studies (both in 
vivo and in vitro) have demonstrated that Biosilicate® 
has high osteogenic potential. Moura et al(5)  showed 
that Biosilicate® can induce bone tissue formation 
in a culturing system for osteoblastic cells. In an in 
vivo study, Granito et al(7) observed that there was 
greater bone formation in defects filled with Bio-
silicate® than in those filled with bioglass 45S5®, 
which is currently considered to be the gold standard 
for bioactive materials. 
Following the positive results from Biosilicate® in 
the bone repair process, a hypothesis that the effect 
from this material could be boosted through laser ir-
radiation and/or ultrasound energy was raised. How-
ever, the results from the present study demonstrated 
that the animals whose bone defects were filled with 
Biosilicate® also received LLLT and US therapy pre-
sented a significant decrease in the quantity of neo-
formed bone tissue, compared with the control group. 
The mechanism through which this occurs is un-
clear. It is known that Biosilicate® is a highly bioac-
tive glass ceramic(5) and that both LLLT and US have 
high osteogenic potential(11,18). One hypothesis may be 
that associating these types of treatment might have 
caused excessive stimulation to the lesion site. In ad-
dition, parameters like power, wavelength and flu-
ence may have influenced this process and may have 
inhibited cell migration and growth on the surface of 
the glass ceramic. 
Similar results were found by Rennó et al(19), who 
conducted an in vitro evaluation on the effects of laser 
therapy at 830 nm and 10 J/cm2 on the proliferation 
of osteoblastic cells on Biosilicate® scaffolds. It was 
demonstrated that MC3T3 cells grew successfully on 
scaffolds composed of Biosilicato®, with osteoblast 
cells presenting normal morphology and easily adhe-
ring and proliferating by means of the disc surfaces. 
On the other hand, laser irradiation produced a 13% 
decrease in osteoblast proliferation (MC3T3) in the 
Biosilicate® discs.
Some resent studies have reported that there is an 
increase in osseointegration between bone tissue and 
implants subsequent to laser and US. In a study asses-
sing the effects of LLLT on hydroxyapatite implants, 
satisfactory results were found. LLLT using GaAsAl 
at 780 nm was found to promote a greater degree of 
osseointegration at the bone-hydroxyapatite interface, 
thus suggesting that LLLT may be considered to be a 
good tool for boosting the bone-implant interface in 
orthopedic surgery(20). AboElsaad et al(21) evaluated 
the effects of LLLT using 830 nm and bioactive glass 
implants in periodontal defects. The results showed 
that LLLT in association with biomaterial had a posi-
tive effect with regard to accelerating the periodontal 
repair. In a study evaluating the action of US on bone 
growth in hydroxyapatite implants, Iwai et al(22) found 
positive results from US associated with the bioma-
terial. US was capable of increasing the number of 
osteoblasts and the quantity of bone in hydroxyapatite 
implants.
CONCLUSION
Based on the results from this study, we can con-
clude that Biosilicate® was capable of accelerating 
and boosting bone recovery, through modulating the 
inflammatory process and stimulating new bone tissue 
formation. However, when LLLT or US were used in 
association, no positive results were found. 
 FG               BG              BLG            BUSG
Area of neoformed bone
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